CG Oncology, Inc. CGON
Set alert
65.60 USD +3.64 +5.87%
As of Nov 3, 2:07 PM ET
62.35 Day range 65.79
35.80 52-week range 80.97
- YTD
- +58.00%
- 1 year
- +56.56%
- Open
- 62.52
- Prev close
- 61.96
- Mkt cap
- 5.82B
- Vol
- 254.20K
- Avg vol
- 883.07K
- EPS
- -2.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 62.35
- High
- 65.79
- Forward P/E
- -20.51
- Beta
- 0.35
- Short ratio
- 8.13
- Inst. own
- 113.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2026
- 50-d avg
- 69.43
- 200-d avg
- 65.90
- 1y target
- 91.08
5D chart
Signals (103)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 3, 9:35 AM | 4 hours ago |
| SMA: Bullish | Nov 3, 9:30 AM | 4 hours ago |
| SMA: Bullish | Nov 3, 9:30 AM | 4 hours ago |
| SMA: Bearish | Nov 2, 3:45 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 3:30 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 3:20 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 22 hours ago |
| RSI: Overbought | Nov 2, 2:35 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 1:55 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:50 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:50 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:40 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:30 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:25 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:25 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:20 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:10 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:05 PM | 1 day ago |
Newest 20 of 103.
Financial health
Altman Z-Score
58.05 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -20.0×
FY 2021 5y median -36.4× FY 2025
P/S 794×
FY 2021 5y median 1574× FY 2025
P/B 4.3×
FY 2021 5y median 13.4× FY 2025
P/FCF -24.2×
FY 2021 5y median -54.2× FY 2025
EV/EBITDA -20.0×
FY 2021 5y median -50.8× FY 2025
EV/Sales 788×
FY 2021 5y median 1348× FY 2025
FCF Yield -4.1%
FY 2021 5y median -1.8% FY 2025
Profitability
Gross Margin -15.0%
FY 2021 5y median -15.0% FY 2025
Operating Margin -4722.1%
FY 2021 5y median -10067.3% FY 2025
Net Margin -3985.0%
FY 2021 5y median -7729.5% FY 2025
ROE -21.4%
FY 2021 5y median -26.3% FY 2025
ROIC -25.0%
FY 2021 5y median -24.9% FY 2025
ROA -20.3%
FY 2021 5y median -21.9% FY 2025
Growth (YoY)
Revenue 254.7%
FY 2021 FY 2025
Operating Income -66.4%
FY 2021 FY 2025
EPS (diluted) -47.5%
FY 2021 FY 2025
Free Cash Flow -67.8%
FY 2021 FY 2025
Financial Health
Current Ratio 24.6×
FY 2021 5y median 13.6× FY 2025
Quick Ratio 24.6×
FY 2021 5y median 13.6× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2021 5y median 2.0× FY 2025
Interest Coverage 0.0×
FY 2021 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31